All Stories

  1. Novel plasminogen gene mutations in Turkish patients with type I plasminogen deficiency
  2. A comparison of healthy infants and adults with respect to indirect microparticle activity and the parameters of thrombin generation test
  3. SPATIALLY EXPLICIT MODELS TO INVESTIGATE GEOGRAPHIC PATTERNS IN THE DISTRIBUTION OF FORENSIC STRs
  4. Grandmother's effect on child weight in Turkish Community
  5. Detection of TET2, KRAS and CBL variants by Next Generation Sequencing and analysis of their correlation with JAK2 and FLT3 in childhood AML
  6. Hemoglobin H Disease in Turkey: Experience from Eight Centers
  7. Behçet's: A Disease or a Syndrome? Answer from an Expression Profiling Study
  8. Endothelial Cells, Ankaferd Hemostat, And Estradiol
  9. Antibacterial activities of Ankaferd Hemostat (ABS) on ‘Shiga toxin producing Escherichia coli’ and other pathogens significant in foodborne diseases
  10. The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β0-thalassaemia homozygotes
  11. Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids
  12. A Further Note on the Thalassemia Screening Program in the Muğla Region of Turkey
  13. Radioactive fallout and neural tube defects
  14. C-type lectin domain family 12, member A: A common denominator in Behçet’s syndrome and acute gouty arthritis
  15. Prothrombotic risk factors in childhood migraine and comparison of acetylsalicyclic acid and propranolol in prophylactic therapy
  16. Behçet’s disease as cause of sinovenous thrombosis in a pediatric patient
  17. Phylogeographic Refinement and Large Scale Genotyping of Human Y Chromosome Haplogroup E Provide New Insights into the Dispersal of Early Pastoralists in the African Continent
  18. A Novel Beta Globin Gene Polymorphism in Turkish Population: IVS-II 706 G>A
  19. A Novelist Observation on Emotional Deprivation During the First World War
  20. Nail Destruction Due to “Print Correction Fluid”
  21. Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann’s thrombasthenia
  22. High iron content of Ankaferd hemostat as a clue for its hemostatic action of red blood cell origin
  23. Ankaferd Blood Stopper induces apoptosis and regulates PAR1 and EPCR expression in human leukemia cells
  24. γA gene repeats polymorphism for the analysis of haplotypes of abnormal hemoglobins
  25. Hemoglobin Lansing (Alpha) [HBA2 CD87 (HIS>GLU) (C>A)] in a Turkish Individual Resulting from Another Nucleotide Substitution
  26. Does FVL have an effect on longevity?
  27. An Updated Review of Abnormal Hemoglobins in the Turkish Population
  28. Evaluation of indirect microparticle activity and parameters of thrombin generation test in healthy infants
  29. Naming a novel hemoglobin variant
  30. An Analysis of the Levels of the Soluble Form of the Endothelial Protein C Receptor in Children with Henoch–Schönlein Purpura
  31. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls
  32. Genome-Wide Transcriptional Reorganization Associated with Senescence-to-Immortality Switch during Human Hepatocellular Carcinogenesis
  33. A novel protein C inhibitor gene mutation in pediatric stroke patients after bone marrow transplantation
  34. Blood group genotyping in multi-transfused patients
  35. Endothelial Protein C Receptor and Pediatric Arterial Stroke
  36. Three thousand eight hundred-year-old toys of the Hittites
  37. Effect of Factor V Leiden on Thrombosis in Childhood Leukemia
  38. Identification of four common α-thalassemia gene deletions among a group with hemoglobinopathies in Sétif population, Algeria
  39. C0369 Factor V leiden and prothrombin 20210A mutations among turkish pediatric leukemia patients
  40. C0377 Does FVL have an effect on longevity?
  41. Comprehensive identification of erythrocyte membrane protein deficiency by 2D gel electrophoresis based proteomic analysis in hereditary elliptocytosis and spherocytosis
  42. Inherited Thrombophilia in Pediatric Ischemic Stroke: An Egyptian Study
  43. Methylenetetrahydrofolate reductase gene polymorphism in type 1 diabetes mellitus: Relationship to microvascular complications
  44. Intron F G79A Polymorphism of the Protein Z Gene in Turkish Behçet Patients
  45. Neural Tube Defects in Algeria
  46. To the editor
  47. Endothelial Dysfunction and Vitamin D Levels in Kidney Allograft Recipients
  48. Nutritional Factors, Homocysteine and C677T Polymorphism of the Methylenetetrahydrofolate Reductase Gene in Algerian Subjects with Cardiovascular Disease
  49. TNF-α-308 G/A Polymorphism in Egyptian Budd-Chiari Syndrome Patients
  50. First Observation of Hemoglobin M Saskatoon (�63 (E7) His>Tyr(C-T)) in the Iraqi Population
  51. Dual Diverse Dynamic Reversible Actions of Ankaferd on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS
  52. A novel homozygous nucleotide deletion at JAK�2 gene in a pediatric B-cell precursor acute lymphoblastic leukemia
  53. Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
  54. The value of procalcitonin measurements in children with familial Mediterranean fever
  55. Role of ZIP14 (SLC39A14) gene histidine rich regions in neural tube defects
  56. Lipoprotein A Levels in Pediatric Migraine
  57. Thrombotic gene polymorphisms and postoperative outcome after coronary artery bypass graft surgery
  58. The Association of Protease Activated Receptor 1 gene −506 I/D Polymorphism with Disease-Free Survival in Breast Cancer Patients
  59. The incidence of alpha-thalassemia in Iraqi Turks
  60. The importance of studying inherited hematological disorders in ancient Anatolian populations
  61. A novel 110 bp insertion in a patient with homocystinuria
  62. First observation of MTHFR 678 C-A (Ala222Ala) single nucleotide polymorphism
  63. The frequency of Factor V 1691G-A mutation in Iraqi Turks
  64. Endothelial Protein C Receptor gene expression in a woman with homozygous EPCR 23 bp insertion
  65. The frequency of FV G1691A and PT G20210A mutations in an Albanian population
  66. The effects of Ankaferd Blood Stopper on transcription factors in HUVEC and erythrocyte protein profile
  67. The effects of endothelial protein C receptor gene polymorphisms on sEPCR levels in venous thrombotic patients
  68. Dual diverse dynamic reversible actions of Ankaferd on EPCR and PAI-1 inside vascular endothelial cells with and without LPS
  69. First observation of hemoglobin Crete (B129 (H7) Ala>Pro) in Turkish population
  70. The role of tumor necrosis factor-alpha -308 G/A and transforming growth factor-beta 1 -915 G/C polymorphisms in childhood idiopathic thrombocytopenic purpura
  71. Proteomic identification of erythrocyte membrane protein deficiency in hereditary spherocytosis
  72. Kikuchi-Fujimoto Disease Associated with Aseptic Meningitis: A Case Report
  73. Childhood migraine and hypercoagulopathy
  74. Hemoglobin alpha 2 gene +861 G>A polymorphism in Turkish population
  75. A novel MEFV gene mutation (A511V) in a Chilean FMF patient
  76. Protease activated receptor 1 gene −506 I / D polymorphism in cancer patients with and without venous thrombosis
  77. Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients
  78. The relation between soluble endothelial protein C receptor and factor VIII levels and FVIII/sEPCR index in healthy infants
  79. Contribution of clinical, metabolic, and genetic factors on hypertension in obese children and adolescents
  80. Thrombosis and risk factors
  81. The incidence of alpha-thalassemia in Setif, Algeria
  82. Association of Methylenetetrahydrofolate Reductase C677T and Cystathionine β-Synthase Polymorphisms in Cardiovascular Disease in the Algerian Population
  83. Functional proteomic analysis of Ankaferd® Blood Stopper
  84. Ribosomal protein S19 - 631 insertion is an African-originated mutation
  85. Methylenetetrahydrofolate reductase C677T polymorphism in breast cancer risk
  86. A Truncating Mutation in SERPINB6 Is Associated with Autosomal-Recessive Nonsyndromic Sensorineural Hearing Loss
  87. A novel mutation of 5α-steroid reductase 2 deficiency (CD 65 ALA-PRO) with severe virilization defect in a Turkish family and difficulty in gender assignment
  88. Association between the −402GA, −401GT, and −323ins10-bp polymorphisms of factor VII gene and breast cancer
  89. Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular Disease
  90. Association of the tumor necrosis factor-alpha −308 G/A polymorphism with nasal polyposis
  91. Soluble endothelial cell protein C receptor and thrombomodulin levels after renal transplantation
  92. SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR LEVEL IN CHILDREN WITH SEPSIS
  93. Relationship between functional promoter polymorphism in the XBP1 gene (−116C/G) and atherosclerosis, ischemic stroke and hyperhomocysteinemia
  94. Response
  95. Cerebral infarct associated with prothrombin gene G 20210 A variant in a Turkish child with cystic fibrosis: an unusual coexistence
  96. Soluble endothelial protein C receptor levels in healthy population
  97. A note on Homocysteine levels in Children
  98. Thrombophilic Risk Factors in Epileptic Children Treated with Valproic Acid
  99. The effects of tamoxifen on homocysteine levels in breast cancer patients
  100. SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR LEVEL IN CHILDREN WITH SEPSIS
  101. Polymorphisms of 5,10-Methylenetetrahydrofolate Reductase and Cystathionine β-Synthase Genes as a Risk Factor for Neural Tube Defects in Sétif, Algeria
  102. Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer
  103. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis
  104. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement
  105. Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer
  106. Serum Endothelial Monocyte-Activating Polypeptide–II: A Novel Biomarker in Patients with Non–Small-Cell Lung Cancer
  107. Paternal X could relate to arithmetic function; study of cognitive function and parental origin of X chromosome in Turner syndrome
  108. Thrombophilia-associated gene mutations in women with pregnancies complicated by fetal neural tube defects
  109. Intron F G79a polymorphism of the protein Z gene in cancer patients with and without thrombosis
  110. Relationship between susceptibility to antimicrobials and virulence factors in paediatric Escherichia coli isolates
  111. MEF2A Sequence Variants in Turkish Population
  112. Prevalence of the MEFV Gene Mutations in Childhood Polyarteritis Nodosa
  113. Off-pump coronary artery bypass graft surgery after stent implantation in a patient with combined thrombophilic risk factors
  114. Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients
  115. Homozygous Mutations in Fibroblast Growth Factor 3 Are Associated with a New Form of Syndromic Deafness Characterized by Inner Ear Agenesis, Microtia, and Microdontia
  116. EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients
  117. Idiopathic portal vein thrombosis and FVIII levels
  118. Vascular endothelial growth factor C936T polymorphism in cancer patients with thrombosis
  119. Serum Pro-Hepcidin Levels and Relationship with Ferritin in Healthy Non-Anaemic Infants
  120. HOMOZYGOUS 23-bp INSERTION OF ENDOTHELIAL PROTEIN C RECEPTOR GENE IN A CHILD WITH FATAL SEPSIS
  121. A further note on thrombosis in patients with homozygous beta thalassemia
  122. No Relation between Angiotensin-Converting Enzyme Gene Polymorphism and Pseudoexfoliation
  123. Prevalence of Factor V 1691 G–A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients
  124. Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer
  125. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis
  126. Does SLC30A4 (ZNT4) gene exon 5 915 T-C alteration play a role in neural tube defects?
  127. Noma
  128. Pediatric Stroke, Homocysteine and MTHFR 677C-T and 1298 A-C
  129. Prothrombin Gene 20209 C>T Along with the First Description of a Homozygous Polymorphism at the 3′ Downstream Region +4 C>T in the Turkish Population
  130. Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation – response
  131. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis
  132. 23-bp endothelial protein C receptor (EPCR) gene insertion mutation in cancer patients with and without thrombosis
  133. High plasma levels of factor VIII: An important risk factor for isolated pulmonary embolism
  134. A germlinePTEN mutation with manifestations of prenatal onset and verrucous epidermal nevus
  135. Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation
  136. Restriction Endonuclease Analysis as a Solution for Determining Rifampin Resistance Mutations by Automated DNA Sequencing in Heteroresistant Mycobacterium tuberculosis Strains
  137. Is Tissue-Plasminogen Activator Gene Polymorphism a Risk Factor for Venous Thromboembolism in Every Population?
  138. TNF-α −308G/A and IL-6 −174 G/C polymorphisms in the Turkish pediatric stroke patients
  139. Elevated FVIII and FIX level in a Behçet's disease patient with intracardiac thrombosis and pulmonary arterial aneurysms
  140. 657del5 Mutation of the Nijmegen Breakage Syndrome Gene (NBS1) in the Turkish Population
  141. SERUM SOLUBLE TRANSFERRIN RECEPTOR IS A VALUABLE DIAGNOSTIC TOOL IN IRON DEFICIENCY OF BREATH-HOLDING SPELLS
  142. FAMILIAL HIGH FACTOR VIII LEVEL IN A CHILD WITH NECROTIZING FASCIITIS COMPLICATING PRIMARY VARICELLA INFECTION
  143. Sequence Analysis of rpoB Mutations in Rifampin-Resistant Clinical Mycobacterium tuberculosis Isolates from Turkey
  144. The KBG syndrome: Confirmation of autosomal dominant inheritance and further delineation of the phenotype
  145. High factor VIII levels during attacks of familial Mediterranean fever
  146. Natural immunity to Haemophilus influenzae type B in children of Ankara, Turkey
  147. Phylogeographic Analysis of Haplogroup E3b (E-M215) Y Chromosomes Reveals Multiple Migratory Events Within and Out Of Africa
  148. Effect of Factor VIIIc Levels in Pediatric Stroke Patients
  149. THE EFFECTS OF ACUTE INFECTION ON HEMATOLOGICAL PARAMETERS
  150. Evaluation of Erythropoiesis by Serum Transferrin Receptor and Ferritin in Infants Aged 0–6 Months
  151. Factor V Leiden and Prothrombin Gene 20210A Variant in Neonatal Thromboembolism and in Healthy Neonates and Adults: A Study in a Single Center
  152. First observation of homozygous hemoglobin hamadan (B 56 (D7) GLY-ARG) and beta thalassemia (-29 G>A)- hemoglobin Hamadan combination in a Turkish family
  153. Effect of Twice Weekly Versus Daily Iron Treatment in Turkish Children with Iron Deficiency Anemia
  154. Spectrum of GJB2 mutations in Turkey comprises both Caucasian and Oriental variants: Roles of parental consanguinity and assortative mating
  155. Ligneous conjunctivitis, hydrocephalus, hydrocele, and pulmonary involvement in a child with homozygous type I plasminogen deficiency
  156. Factor VIII levels in children with thrombosis
  157. PT G20210A, factors V G1691A and 1299 His–Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer
  158. Letter to the Editor
  159. Effect of Twice Weekly Versus Daily Iron Treatment in Turkish Children with Iron Deficiency Anemia
  160. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish Familial Mediterranean Fever patients with and without amyloidosis
  161. Factor V Leiden and Prothrombin Gene 20210A Variant in Neonatal Thromboembolism and in Healthy Neonates and Adults: A Study in a Single Center
  162. Factor V Gene (1691A and 4070G) and Prothrombin Gene 20210A Mutations in Patients with Behçet’s Disease
  163. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium
  164. Three risk factors—high lipoprotein (a), elevated FVIII, and FV Leiden—in a pediatric Behçet's disease patient with deep vein thrombosis
  165. Does early erythropoietin therapy decrease transfusions in anemia of prematurity ?
  166. Arthritis in children with familial Mediterranean fever
  167. RED BLOOD CELL INDEXES IN PATIENTS WITH HEREDITARY SPHEROCYTOSIS AND β-THALASSEMIA COMBINATION
  168. HIGH LEVELS OF FVIII AND FIX IN A PEDIATRIC PATIENT WITH RETINAL ARTERY OCCLUSION
  169. RECURRENT ARTERIAL THROMBOSIS IN A CHILD: Primary Antiphospholipid Antibody Syndrome
  170. Tüberküloza Genetik Yatkınlık
  171. Is high levels of factor VIII a possible risk factor for intracardiac thrombosis?
  172. E148Q of the MEFV Gene Causes Amyloidosis in Familial Mediterranean Fever Patients
  173. Connexin 26 ( GJB2 ) mutations in the Turkish population: implications for the origin and high frequency of the 35delG mutation in Caucasians
  174. Common Mutations at the Homocysteine Metabolism Pathway and Pediatric Stroke
  175. The α2 Gene Alleles of the Platelet Collagen Receptor Integrin α2β1 in Turkish Children with Cerebral Infarct
  176. Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction
  177. Isolated recurrent pericarditis in a patient with familial Mediterranean fever
  178. Possible effects of antioxidant status on increased platelet aggregation in childhood iron-deficiency anemia
  179. Compound heterozygosity for factor V Leiden and prothrombin G20210A mutations in a child with Budd-Chiari syndrome
  180. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism in Turkish Children With Cerebral Infarct and Effect on Factor V 1691 A Mutation
  181. Factor V 1691G-A mutation and high factor VIII levels in a patient with intracardiac thrombosis
  182. The Role of Prothrombotic Mutations in Patients with Buerger's Disease
  183. No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke
  184. MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis?
  185. Prothrombin Gene 20210 G→A and Factor V Arg 506 to Gln Mutation in a Patient with Buerger's Disease
  186. Spina bifida and common mutations at the homocysteine metabolism pathway
  187. Effect Of Metylenetetrahydrofolate Reductase 677 C-T, 1298 A-C, and 1317 T-C on Factor V 1691 Mutation in Turkish Deep Vein Thrombosis Patients
  188. Factor V (his 1299 arg) in Turkish patients with venous thromboembolism
  189. Coexistence of factor V 1691 G-A and factor V 4070 A-G mutation in Turkish thromboembolic patients
  190. Factor V (His 1299 Arg) in Young Turkish Patients with Cerebral Infarct
  191. Renal Amyloidosis in a Patient with Homozygous Sickle Cell Anemia and M694V/M694V Mutation
  192. Effect of desferrioxamine on urinary copper and zinc excretion in β-thalassemia major patients
  193. MEFV mutations in Turkish patients suffering from familial Mediterranean fever
  194. Effect of desferrioxamine on urinary copper and zinc excretion in ?-thalassemia major patients
  195. Recombinant human growth hormone treatment in children with thalassemia major
  196. Recombinant human growth hormone treatment in children with thalassemia major
  197. Feasibility of restriction enzyme protocols for the molecular diagnosis of abnormal hemoglobins in Turkish population
  198. Feasibility of restriction enzyme protocols for the molecular diagnosis of abnormal hemoglobins in Turkish population
  199. Plasma endothelin-1 levels in patients with left-to-right shunt with or without pulmonary hypertension
  200. Endothelial Nitric Oxide Synthase Intron 4, 27 bp Repeat Polymorphism in Turkish Patients with Deep Vein Thrombosis and Cerebrovascular Accidents
  201. Methylenetetrahydrofolate-Dehydrogenase 1958 G-A (R653 Q) Polymorphism in Turkish Patients with Venous Thromboembolism
  202. COEXISTENCE OF TWO PROTHROMBOTIC MUTATIONS, FACTOR V 1691 G-A AND PROTHROMBIN GENE 20210 G-A, AND THE RISK OF CEREBRAL INFARCT IN PEDIATRIC PATIENTS
  203. Oxygen Free Radical-Dependent Increased Platelet Function in β-Thalassemia Major Patients
  204. Search for Genetic Factors Favoring Thrombosis in Turkish Population
  205. Prothrombin gene 20210 G-A mutation in the Turkish population
  206. Familial Mediterranean Fever — Amyloidosis and the Val726Ala Mutation
  207. Further note for the discrimination of Hb C
  208. α-Thalassemia and Hereditary Spherocytosis in the Same Patient: The Interaction of two Diseases
  209. Serum Interleukin-2 and Interleukin-6 Levels in IRON Deficiency Anemia
  210. Effect of 1,2‐Dimethyl‐3‐Hydroxypyridin‐4‐One (L1) on zinc absorption
  211. Effect of 1,2-Dimethyl-3-Hydroxypyridin-4-One (L1) on zinc absorption
  212. Letter to the Editor: Serum Superoxide Dismutase Levels of Beta Thalassemia Patients and Effects of High Dosage of Intravenous Desferrioxamine Treatment on Superoxide Dismutase Levels
  213. Further delineation of the molecular pathology of Wilson disease in the Mediterranean population
  214. Further delineation of the molecular pathology of Wilson disease in the Mediterranean population
  215. Differential Structuring of Human Populations for Homologous X and Y Microsatellite Loci
  216. Coffee beans pica causing iron and zinc deficiency
  217. Pregnancy outcome of mothers with defective oral zinc tolerance test
  218. Wilson disease mutations associated with uncommon haplotypes in mediterranean patients
  219. Direct detection of Hb C (B6 Glu-Lys) byBseRI analysis
  220. Erythrocyte P Antigen in Beta Thalassemia Major Patients with Human Parvovirus-B19 Infection
  221. A Case of Severe Thrombocytopenia Due to Parvovirus B19 Virus
  222. Verification of Hb O-Arab [β121(GH4)GLU → LYS] by Dual Restriction Enzyme Analysis
  223. Tuberculous osteomyelitis: an unusual case of tuberculous infection in a child undergoing continuous ambulatory peritoneal dialysis
  224. Effects of Calcitonin Therapy on Osteoporosis in Patients with Thalassemia
  225. p53 Codon 213 (A-G) Polymorphism in a Turkish Population
  226. Incidence of Parvovirus B19 Infection Among Thalassemia Major Patients from Ankara, Turkey
  227. GM-CSF in the treatment of Fanconi's anaemia
  228. Rapid Diagnosis Of Two β-Thalassemia Mutatlons: Frameshift Codon 5 (-CT) And Codon 6 (-A)
  229. Burkitt's lymphoma between African and American types in Turkish children: Clinical, viral (EBV), and molecular studies
  230. Desferoxamine and Urinary Zinc Excretion in β-Thalassemia Major
  231. Hemoglobinopathies in the District of Antalya, Turkey
  232. Effects of zinc supplementation on somatomedin-C level, in beta thalassemia
  233. Doppler Color Flow Imaging for the Evaluation of Postsplenectomy Portal Vein Thrombosis in Pediatric Hematological Diseases
  234. Ultrastructural Changes in the Mucosa of the Small Intestine in Patients with Geophagia (Prasadʼs Syndrome)
  235. NAEVUS OF JAMAICA
  236. High incidence of neural tube defects in Bursa, Turkey
  237. ANOREXIA AND ZINC
  238. Prevalence of Thalassemia and G6PD Deficiency in North Cyprus
  239. Modernizer of Turkey's Pediatrics: Albert Eckstein in Exile
  240. Further Notes on Albert Eckstein: The Modernizer of Turkey's Pediatrics